Literature DB >> 27234349

Ménière's Disease and Underlying Medical and Mental Conditions: Towards Factors Contributing to the Disease.

Shwan Mohamed1, Imran Khan, Stamatina Iliodromiti, Margaret Gaggini, Georgios Kontorinis.   

Abstract

PURPOSE OF THE STUDY: To investigate the relation of Ménière's disease (MD) with medical comorbidity or mental conditions. PROCEDURES: Demographic data, medical and mental comorbidities were retrospectively collected and compared from 3 groups of 30 patients each: a group with patients with definite MD, a second one with patients with vestibulopathies other than MD (non-Ménière's vertigo, NMV) and a third one with patients without any vestibular symptoms (control). The level of significance was set at 0.05.
RESULTS: The prevalence of mental conditions was 26.7, 23.3 and 6.7% for the MD, the NMV and the control group, respectively. Medical comorbidity was found in 80% of patients in the MD, 63% in the NMV and 20% in the control group. Arthritis was encountered in 8 patients with MD, 3 with NMV and none from the control group. The differences in prevalence of mental disease, comorbidities and arthritis between the MD and the control group were statistically significant (p = 0.02, p < 0.001 and p = 0.008, respectively).
CONCLUSION: Psychological conditions play an important role in patients with MD. The significantly increased prevalence of arthritis in the MD group suggests an inflammatory/autoimmune background as a contributing factor to the disease.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27234349     DOI: 10.1159/000444931

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  4 in total

1.  The imaging of the dizzy patient: computed tomography versus magnetic resonance imaging.

Authors:  Georgios Kontorinis
Journal:  Eur Radiol       Date:  2018-04-30       Impact factor: 5.315

2.  Anatomical variation of inner ear may be a predisposing factor for unilateral Ménière's disease rather than for ipsilateral delayed endolymphatic hydrops.

Authors:  Ping Lei; Yangming Leng; Jing Li; Renhong Zhou; Bo Liu
Journal:  Eur Radiol       Date:  2022-01-03       Impact factor: 7.034

3.  Duration of symptom control following intratympanic dexamethasone injections in Meniere's disease.

Authors:  Aidan Hilton; Alison McClelland; Rhona McCallum; Georgios Kontorinis
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-04-10       Impact factor: 3.236

4.  Pharmacologic and surgical therapies for patients with Meniere's disease: a protocol for a systematic review and meta-analysis.

Authors:  Nadera Ahmadzai; Wei Cheng; Dianna Wolfe; Jamie Bonaparte; David Schramm; Elizabeth Fitzpatrick; Vincent Lin; Becky Skidmore; Leila Esmaeilisaraji; Shaun Kilty; Brian Hutton
Journal:  Syst Rev       Date:  2019-12-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.